Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma https://t.co/yFnwkmDYUi https://t.co/iCIo3KluRi
17,538 followers
476 followers
RT @FrontImmunol: New Research: Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a pati…
32,876 followers
New Research: Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma: Anti-PD-1 immunotherapy has been extensively used in treatment of… https://t.co/Li1b